To strengthen the U.S. lead in the bioeconomy, Congress recently passed the CHIPS & Science Act of 2022. While the main body of this bill is related to semiconductors, this bill also lays out a solid base for the bioeconomy. Shortly after the passing of the CHIPS & Science Act, the White House also published an Executive Order that […]
Over the past year, there have been significant policy advances related to the US bioeconomy—the part of the economy driven by the life sciences and biotech, and enabled by engineering, computing, and information science.1 The bioeconomy includes a wide range of products and processes, from mRNA vaccines and drought-resistant crops to microbial fertilizers and bioindustrial fermentation. […]
The COVID-19 pandemic has highlighted the essential importance of biomanufacturing capabilities—extending to the geopolitical level—as well as the fragility of many supply chains and processes.
The U.S. government should create a Bio for America Program Office (BAPO) at the National Institute for Standards and Technology (NIST) to house a suite of initiatives that would lead to the creation of more well-paying U.S.-based biomanufacturing jobs and more.
Streamlined funding of open and cross-disciplinary research, prize and challenge mechanisms, and market shaping through innovative procurement have all proven highly effective in the face of market failures and applied technology gaps like those seen in our bioindustry.
For the United States, the economic, societal, and national security benefits of the life sciences are vast. The U.S. bioeconomy – the part of the economy driven by the life sciences and biotech, and enabled by engineering, computing, and information science – is valued at over $950 billion. Life sciences research leads to cleaner crops […]
Plants are key to enable a diversified and climate-resilient food system. Mary Fernandes proposes a Plant Genome Project (PGP), a robust Human Genome Project-style initiative to build a dataset of genetic information on plant species.
Congress had a lot more on its agenda than semiconductors when compiling the CHIPS and Science Act of 2022. The bill–law as of yesterday–puts forward an expansive framework to advance U.S. innovation broadly, including in areas that feed into a critical sector: the bioeconomy.
The federal government can accelerate capabilities and applications of environmental biotechnology by establishing the CLimate Improvements through Modern Biotechnology (CLIMB) Center.
This is the ideal time to expand U.S. climate strategy into an “all of the above” solution that includes carbon capture and storage as a core component.
Research into senescent cells could result in extended human lifespans and significant policy implications Improved housing, sanitation, and healthcare have significantly increased humans’ life expectancy, and biomedical advances have the potential to further extend people’s lives. The life expectancy of a person born in 1860 was only about 39 years; a person born today can […]
To reduce the burden on traditional data centers, improving on DNA data storage could be the key The pace at which data – such as photos, videos, and social media posts – are being generated is ramping up drastically, exceeding the scaling limits of traditional silicon-based data storage technologies, and DNA could be deployed to […]